The Daily Mail says it is developing a new offering for its readers and is seeking their opinions before finalizing its details. In a short announcement, the outlet states that it cannot share everything about the proposed project yet because readers will help determine what it ultimately becomes. The publication frames the request as a way for its audience to shape the concept during the planning stage rather than after it launches. Beyond inviting reader feedback, the announcement does not provide specific information about the format, subject matter, timeline, or goals of the planned initiative. The message focuses on participation, indicating that the newsroom will use input from readers to guide the next steps in building the project. Overall, the reports present the story as an early-stage consultation with the audience rather than a confirmed description of what will be launched.
Daily Mail asks readers for input on a new project
The Daily Mail says it is developing a new offering for its readers and is seeking their opinions before finalizing its details. In a short announcement, the outlet states that it cannot share everyth...
- The Daily Mail says it is creating a new project for readers.
- The outlet is asking readers for their opinions before building it.
- Details of the project are not yet fully disclosed.
- The publication indicates reader input will influence what the final offering becomes.
We can't tell you everything yet, because you're going to help decide what it becomes.
5 hours agoWe can't tell you everything yet, because you're going to help decide what it becomes.
5 hours ago
FDA approves Merck’s Lipfendra, a first once-daily oral PCSK9 inhibitor for high LDL
The U.S. Food and Drug Administration has approved Lipfendra (Merck) as a once-daily oral medication for lowering LDL (“...
Two Roush-modified Ford Mustang 427R and 380R models are listed for sale online
Bring a Trailer lists two distinct Roush-modified Ford Mustangs for sale, both presented as lightly used and equipped wi...
Eli Lilly agrees to acquire AtaiBeckley in up to $3.8 billion psychedelic deal
Eli Lilly has agreed to acquire AtaiBeckley, a psychedelics-focused biopharmaceutical company, in a deal reported as wor...